BMRN vs UNH · P/E 40, rev $1.76B vs P/E 30, rev $112.03B
Biomarin Pharmaceutical Inc (BMRN) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the BMRN and UNH stock pages for the full models.
Not investment advice.